Announcement • Jul 07
The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025 The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025. Announcement • Nov 01
The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024 In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended. New Risk • Jul 07
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). 
